<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/"
    xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:schema="http://schema.org/" xmlns:sioc="http://rdfs.org/sioc/ns#"
    xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" version="2.0"
    xml:base="http://www.fda.gov/about-fda/contact-fda/stay-informed/rss-feeds/drug-recalls/rss.xml">
    <channel>
        <title>Drug Recalls</title>
        <link>
            http://www.fda.gov/about-fda/contact-fda/stay-informed/rss-feeds/drug-recalls/rss.xml
        </link>
        <description />
        <language>en</language>

        <item>
            <title>Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan
                Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts
                of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Impurity
            </title>
            <link>
                http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vivimed-life-sciences-pvt-ltd-issues-voluntary-nationwide-recall-losartan-potassium-25-mg-50-mg-and
            </link>
            <description>Vivimed Life Sciences Pvt Ltd (Vivimed) is recalling 19 lots of Losartan
                Potassium Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. Due to the
                detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – that is
                above the US Food &amp; Drug Administration’s interim acceptable exposu
            </description>
            <pubDate>
                <time datetime="2019-05-03T19:21:28Z">Fri, 05/03/2019 - 15:21</time>
            </pubDate>
            <dc:creator>FDA</dc:creator>
            <guid isPermaLink="true">
                http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vivimed-life-sciences-pvt-ltd-issues-voluntary-nationwide-recall-losartan-potassium-25-mg-50-mg-and
            </guid>
        </item>

    </channel>
</rss>
